Eisai Creates Center for Genetics Guided Dementia Discovery

Published 3-29-2019
  • Eisai - Center for Genetics Guided Dementia Discovery
  • Eisai - Center for Genetics Guided Dementia Discovery
  • Eisai - Center for Genetics Guided Dementia Discovery

    Courtesy of TRIA.

  • Eisai - Center for Genetics Guided Dementia Discovery

    Courtesy of The Davis Companies.

Eisai is building the $100 million Center for Genetics Guided Dementia Discovery (G2D2) in Cambridge, Mass. Sited in the newly constructed Alewife Research Center, the 50,000-sf neuroscience facility will support exploratory drug research on next-generation dementia therapeutics. Featuring numerous interaction zones and huddle areas, the center will provide open offices, a collaboration hub, flexible meeting rooms, and multidisciplinary open labs for the study of biology, chemistry, and automation. The project team includes architect TRIA, general contractor John Moriarty & Associates, and MEP/FP engineer AHA Consulting Engineers. Occupancy is expected in mid-2019.

Related Organizations
John Moriarty & Associates
General Contractor
AHA Consulting Engineers
MEP/FP Engineer